PureTech Health plc – Half-Year Report Aug 28, 2025 02:00AM
PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement Jun 26, 2025 02:00AM
PureTech Announces Annual Results for Year Ended December 31, 2024 Apr 30, 2025 02:00AM
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies Sep 6, 2024 02:00AM
PureTech Health plc – Half-Year Report Aug 28, 2024 02:01AM


Apr 25, 2024 05:22AM PureTech Announces Annual Results for Year Ended December 31, 2023
Dec 20, 2023 03:56AM PureTech Health Plc (PRTC) Issues Year End Update and Outlook for 2024
Dec 20, 2023 02:00AM PureTech Year End Update and Outlook for 2024
Aug 29, 2023 02:00AM PureTech Health plc – Half-Year Report
Apr 28, 2023 02:00AM PureTech Announces Annual Results for Year Ended December 31, 2022
Dec 22, 2022 02:00AM PureTech Provides End of Year Report on Key Progress
Aug 25, 2022 02:07AM PureTech Health plc – Half-Year Report
Jan 26, 2022 07:02AM PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
Sep 10, 2021 06:00AM PureTech Health Plc's (PRTC) Vor Biopharma (VOR) Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
Sep 10, 2021 02:00AM PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
Aug 24, 2021 02:00AM PureTech Health plc – Half-Year Report
Jul 19, 2021 07:02AM PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
Jul 9, 2021 07:00AM PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leuk
Feb 10, 2021 02:00AM PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering
Feb 5, 2021 06:50AM PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering